Our advisory work starts from a position of respect
for our clients' organization, people,
products and science.
We have devoted our careers to the life
sciences industry and have the deepest respect
and admiration for the participants in it.
OUR TRACK RECORD
We are a very active advisor in the market.
Torreya Partners has successfully closed over
100 assignments since our founding in 2007.
We often take an operating perspective
to strategic and transaction work.
Merger with Assembly Pharmaceuticals
Sale to Lundbeck
Up to $658 million
Sale to Shire
$75 million upfront + milestones
Asia, Africa, Middle East, Latin America
September 22-24, 2014
BioPharm America 7th Annual Partnering Conference (EBD Group)
September 29-October 1, 2014
The Pharmaceutical Strategy Conference (Elsevier)
New York, NY
October 6-8, 2014
AdvaMed - Advanced Medical Technology Association - The MedTech Conference
May 19, 2014
Ventrus Biosciences to Merge With Assembly Pharmaceuticals
May 8, 2014
Lundbeck to acquire Chelsea Therapeutics
May 2, 2014
Fibrotech acquired by Shire for US$75M plus milestones